Does LERCANIDIPINE Cause Hyperkalaemia? 176 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 176 reports of Hyperkalaemia have been filed in association with LERCANIDIPINE. This represents 4.7% of all adverse event reports for LERCANIDIPINE.
176
Reports of Hyperkalaemia with LERCANIDIPINE
4.7%
of all LERCANIDIPINE reports
3
Deaths
78
Hospitalizations
How Dangerous Is Hyperkalaemia From LERCANIDIPINE?
Of the 176 reports, 3 (1.7%) resulted in death, 78 (44.3%) required hospitalization, and 30 (17.0%) were considered life-threatening.
Is Hyperkalaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LERCANIDIPINE. However, 176 reports have been filed with the FAERS database.
What Other Side Effects Does LERCANIDIPINE Cause?
Acute kidney injury (424)
Hypotension (401)
Fall (323)
Hypertension (197)
Drug ineffective (149)
Diarrhoea (122)
Hyponatraemia (122)
Renal impairment (120)
Oedema peripheral (114)
Syncope (114)
What Other Drugs Cause Hyperkalaemia?
METFORMIN (2,565)
SPIRONOLACTONE (2,518)
FUROSEMIDE (2,035)
RAMIPRIL (1,383)
SACUBITRIL\VALSARTAN (1,192)
SULFAMETHOXAZOLE\TRIMETHOPRIM (1,036)
LISINOPRIL (948)
POTASSIUM (944)
BISOPROLOL (850)
TACROLIMUS (713)
Which LERCANIDIPINE Alternatives Have Lower Hyperkalaemia Risk?
LERCANIDIPINE vs LETAIRIS
LERCANIDIPINE vs LETERMOVIR
LERCANIDIPINE vs LETROZOLE
LERCANIDIPINE vs LETROZOLE\RIBOCICLIB
LERCANIDIPINE vs LEUCOVORIN